Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial

Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial

Abstract Purpose We aimed to evaluate the efficacy and safety of 28‐day Cyclic and 84‐day Extended regimens of NPC‐16 (ethinylestradiol 0.02 mg plus levonorgestrel 0.09 mg) in patients with dysmenorrhea. Methods This was a placebo‐controlled, double‐blind, randomized trial conducted in Japan. A tota...

Full description

Bibliographic Details
Main Authors: Tasuku Harada, Mikio Momoeda
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:Reproductive Medicine and Biology
Subjects:
dysmenorrhea
ethinylestradiol
levonorgestrel
low‐dose estrogen/progestin combination product
placebo‐controlled randomized trial
Online Access:https://doi.org/10.1002/rmb2.12373

Internet

https://doi.org/10.1002/rmb2.12373

Similar Items